Government to designate sibutramine as misuse or overuse drug

Published: 2010-09-07 07:00:00
Updated: 2010-09-07 07:00:00
The Korea Food and Drug Administration is soon considering designating weight loss drugs, such as sibutraime or orlistat, as there is a risk that these medicines may induce overuse or misuse.

The drug agency completed its review of the full study report for SCOUT, which was submitted to the KF...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.